Answers are grounded in this paper and cite their sources.
Purpose of Review The herbal supplement and nutraceutical industry has grown immensely over the past two decades, with large increases being driven by patients seeking alternative methods for pain management. Unlike pharmaceuticals, supplements face a low barrier to market entry with lax regulations allowing these products to be sold without pre-market testing. Recent Findings While products like glucosamine and turmeric are commonly used and have demonstrated moderate efficacy for pain conditions such as osteoarthritis, there is a lack of long-term randomized control trials to support widespread use. Additionally, product use is associated with safety concerns stemming from known toxicities, manufacturing contaminants, and herbal-drug product interactions. Summary These limitations have prompted calls for better regulatory oversight of herbal supplements to improve manufacturing standards, recognize safety concerns from product use, and establish long-term data for effective use. Clinicians are also encouraged to recognize known benefits and risks of nutraceutical use to better inform patients using these products and to reduce potential morbidity and mortality.
No takes yet. Share an insight, caveat, or question.
Anwar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: